FDA Inspection 1229622 — Aptar France SAS

Aptar France SAS — FEI 1000190804

The FDA completed an inspection of Aptar France SAS on Feb 8, 2024 in Le Vaudreuil. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 8, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Le Vaudreuil (France)

Citations

IDCFRDescription
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.